Neuro-Oncology by P. PaolettiNeuro-Oncology by P. Paoletti

Neuro-Oncology

byP. PaolettiEditorKintomo Takakura, M.D. Walker

Paperback | October 18, 2012

Pricing and Purchase Info

$163.84 online 
$191.95 list price save 14%
Earn 819 plum® points

Prices and offers may vary in store

Quantity:

In stock online

Ships free on orders over $25

Not available in stores

Title:Neuro-OncologyFormat:PaperbackDimensions:406 pages, 23.5 × 15.5 × 0.01 inPublished:October 18, 2012Publisher:Springer NatureLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9401053901

ISBN - 13:9789401053907

Look for similar items by category:

Reviews

Table of Contents

One Biology and Diagnosis.- 1. Pathology of brain tumors and its clinicobiological correlates.- 2. Immunohistochemistry in brain tumor classification.- 3. Molecular biological events in the selection of chemotherapy resistant-cells in human malignant gliomas.- 4. Expression of multiple activated cellular oncogenes in human brain tumors.- 5. Proliferative potential of astrocytomas and glioblastomas.- 6. The biological relevance of Arachidonic Acid Metabolism in human brain tumors.- 7. Computed tomography and magnetic resonance in the diagnosis of brain tumors.- 8. The application of positron emission tomography in studies of human cerebral glioma.- 9. Angiography in brain tumours.- 10. Stereotactic approach in brain tumors.- 11. Cellular localization of glucocorticoid receptor mRNAs in human CNS tumors by in situ hybridization.- 12. Proto-oncogene expression and proliferative activity in human malignant gliomas.- 13. Coexpression of PDGF and PDGF-receptors genes in human astrocytic gliomas.- 14. Diagnostic and prognostic significance of positron emission tomography in gliomas.- 15. Brain haemodynamics in intracranial supratentorial tumors.- 16. The glycosphingolipids of human astrocytomas.- 17. Findings of aberrant epidermal growth factor receptor in primary human malignant gliomas.- 18. Expression of epidermal growth factor receptor (EGF-R) and Erb-B2 (HER 2/NEU) in glioblastoma (GBM): prognostic relevance.- 19. Evaluation of the proliferative potential of gliomas by KI 67 immunolabelling of stereotactic biopsy samples.- 20. Immunobiology of visualizable brain tumor cells: gamma interferon induces changes in the immune environment in each compartment of brain tumor spread.- 21. Epidemiology of primary cerebral tumors. Results of a multi-center study in the Veneto region of northern Italy.- 22. Simvastatin, a blocker of cholesterol biosynthesis inhibits human glioma cell profileration.- Two Therapy of Gliomas.- 23. Surgery of cerebral gliomas: state of the art.- 24. Advances in neuro-oncology for adult patients with supratentorial gliomas: from the window of radiation oncology.- 25. Recent clinical results in the chemotherapy of brain tumors: BTCG studies.- 26. Clinical application of radiolabeled human X human monoclonal antibody with interferon in the treatment of malignant glioma - preliminary report.- 27. Targeted therapy for CNS tumours with monoclonal antibodies (MAbs).- 28. Early or late surgery for supratentorial gliomas? A randomized study.- 29. Reoperation in the treatment of recurrent intracranial malignant astrocytomas.- 30. Symptomatic subependymoma: a clinico-pathologic and flow cytometric study.- 31. Prognostic factors in anaplastic astrocytomas after surgery and conventional radiotherapy.- 32. Intraoperative radiation therapy (IORT) for cerebral glioblastoma.- 33. Positron emission tomography (PET) applied to stereotactic interstitial brain brachytherapy for malignant glioma patients.- 34. Radiosensitization of human glioma cells by buthionine sulfoximine-induced glutathione depletion.- 35. Degenerative effects of the radiotherapy on the cerebral gliomas.- 36. High dose ACNU chemotherapy with autologous bone marrow transplantation for human malignant brain tumors.- 37. Intrathecal perfusion therapy with nitrosoureas against subarachnoid dissemination of glioma: experimental and clinical studies.- 38. The potential role of lonidamine in the combined treatment of malignant gliomas. A randomized study.- 39. Rabbit brain concentrations of doxorubicin during intraarterial infusions.- 40. 8-chloro-cyclic adenosine monophosphate is a potent inhibitor of human glioma cell proliferation in vitro.- 41. Radiosensitization with carotid arterial infusion of bromodeoxyuridine (BUdR) ± 5 fluorouracil (5FU) biomodulation with focal external beam radiation (FEBT) for malignant gliomas.- 42. Interstitial chemotherapy with drug impregnated polymer implants to treat brain tumors: pre-clinical and clinical studies.- 43. Biologic response to intracavitary interleukin-2/lymphokine activated killer (LAK) cells in the treatment of primary malignant brain tumors.- Three Steroid in Brain.- 44. Role of oxygen radicals in cerebral edema mechanisms: rationale for the use of steroids.- 45. Comparative effects of dexamethasone and methylprednisolone on peritumoral brain edema.- 46. Oral methylprednisolone megadose in the treatment of recurrent gliomas and in-tracranial metastases. Preliminary report.- 47. Effects of methyl-prednisolone on cerebral neoplasms: clinical and radiological evaluation.- 48. Role of glucocorticoid receptors in intracranial tumors.- Four Neurinomas Meningiomas and Other Tumors.- 49. Intracranial meningiomas: state of the art.- 50. Endocrine manipulation of meningiomas with medroxyprogesterone acetate.- 51. Controversies on craniopharyngioma.- 52. Diagnosis and treatment of pineal region tumors.- 53. Primary considerations in an integrated microsurgical-stereotactic approach to lesions affecting the third ventricular chamber.- 54. Optic and chiasm tumors: present perspectives in diagnosis and treatment.- 55. Intracranial metastatic tumors: an overview.- 56. Petroclival meningiomas: their surgical treatment.- 57. Pathology of pinealomas: an immunohistochemical and ultrastructural study.- 58. Statistical analysis of operative mortality and recurrence in intracranial meningiomas.- 59. Surgical management of lateral ventricular tumors.- Five Brain Tumors in Children.- 60. Supratentorial brain tumors in children.- 61. Brain stem gliomas.- 62. Current management of neonatal tumors.- 63. Brain tumors as second malignancies in children treated for acute lymphoblastic leukemia.- Six Intracranial Pressure Management: An Ideal Valve.- 64. The treatment of hydrocephalus in pediatric patients with a variable resistance valve.- 65. The treatment of tumoral hydrocephalus in adults by means of a variable resistance valve.- 66. Advantages of the Orbis-Sigma valve in the treatment of triventricular hydrocephalus.- 67. Reliability and efficacy of different CSF-shunting devices in the treatment of CSF-dynamics disturbances.